Build a world-class scientific, clinical, and entrepreneurial team to create and execute solutions for brain cancer treatment.
Our team is composed of world class experts with vast experience in collaborative research and translating technologies to the clinic. To further expand our community of scholars and technology expertise, we will hire three faculty members in areas of expertise
We have an expansive suite of programmatic activities to foster collaborations and advance the frontiers of knowledge. We also plan to invite thought-leaders in the field and strengthen our engagement with external partners from funding agencies, brain cancer foundations, industry and venture capital communities. Our programs will include:
- Annual Brain Tumor Challenge Summit
- Biennial International Symposium
- Student-led journal club
- Seminar series
- Monthly investigators meetings
We plan to actively participate in community outreach activities to raise public awareness about the disease. We will build upon ongoing efforts within BI and the Rogel Cancer Center to bring attention to Brain Cancer at events such as One Day Closer. We also plan to expand on the 6 weekend-long workshop “Exploring Drug Delivery at the NANO-level” that is organized with the Detroit Area Pre-College Engineering Program (DAPCEP), a non-profit organization with a mission to prepare underrepresented students for careers in engineering and science.
This hands-on course offers the opportunity to expose underrepresented minority students from Detroit inner-city high schools to learning modules in nanotechnology and drug delivery. We also plan to establish close relationships with ChadTough Fund to fund research in DIPG and to participate in yearly American Brain Tumor Association (ABTA) signature Michigan Breakthrough for Brain Tumor 5K walk held in Ann Arbor.
We will work closely with innovation partners on-campus, including the Office of Technology Transfer, to offer training opportunities for our faculty and learners and ensure translation of our technologies.